Lumenis PiQo4
Picosecond Tattoo/Pigment · 532/585/650/1064nm pico+nano
New Lumenis PiQo4 pricing is not published; used and refurbished systems trade around $30k–$55k. Lumenis PiQo4's FDA status is under verification by our research team. Figures are market estimates verified August 9, 2026.
What it's actually cleared for: Multi-wavelength pico/nano tattoo and pigment removal; marketed cleared — K not located
Last verified: August 9, 2026 · How we verify
New: —|Used: $30k–$55kmarket estimate, no email required
| Manufacturer | Lumenis |
|---|---|
| Company | Owner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | 532/585/650/1064nm pico+nano |
| FDA status | Cleared — citation pending verification |
| New price range | Not published |
| Used price range | $30k–$55k |
| Consumables | Not published |
| Launch year | 2017 |
| Last verified | August 9, 2026 |
Overview
Four-wavelength pico, dropped from Lumenis line
FDA & regulatory status
Clearance is expected for this platform, but we have not yet confirmed the exact authorization number against the public FDA database, so no number is published here. See our FDA guide.
What it's actually cleared for:
Multi-wavelength pico/nano tattoo and pigment removal; marketed cleared — K not located
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Lumenis that can affect warranty, service and parts availability.
- Sep 2021
Boston Scientific acquires Lumenis surgical unit for $1.07B
DivestitureBoston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.
Source: Boston Scientific and BPEA press releases
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 9, 2026
FDA status
Cleared → Cleared-Pending-Citation
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.